Inventor
Nikolai Naryshkin
Inventor
East Brunswick, NJ, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes16%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C07KPeptides7%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
10,882,868Compounds for treating spinal muscular atrophy202110,851,101Compounds for treating spinal muscular atrophy202010,688,099Methods for modulating the amount of RNA transcripts202010,668,171Methods for modulating RNA splicing202010,501,482Compounds for treating spinal muscular atrophy2019RE047689Compounds for treating spinal muscular atrophy201910,195,202Methods for modulating the amount of RNA transcripts20199,969,754Compounds for treating spinal muscular atrophy20189,879,007'Compounds for treating spinal muscular atrophy'20189,617,268'Compounds for treating spinal muscular atrophy'20179,586,955'Compounds for treating spinal muscular atrophy'20179,476,870'Methods and agents for screening for compounds capable of modulating gene expression'20169,399,649'Compounds for treating spinal muscular atrophy'20169,376,725'Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulation'20169,068,234'Methods and agents for screening for compounds capable of modulating gene expression'20158,986,935'Methods for treating spinal muscular atrophy'20158,932,818'Screening assays for compounds that modulate programmed ribosomal frameshifting'20158,741,572'Methods of screening for compounds for treating muscular dystrophy using mIGF1 mRNA translation regulation'20148,633,019'Methods for treating spinal muscular atrophy'20148,283,115'Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2021Patents assigned to PTC THERAPEUTICS INC (20)· patent assignee history
2012–2015Patents assigned to WELCH ELLEN (4)· patent assignee history
2012–2020Based in East Brunswick, NJ, US· patent location history
2014–2015Patents assigned to PAUSHKIN SERGEY V (3)· patent assignee history
2015Patents assigned to NARYSHKIN NIKOLAI A (3)· patent assignee history
2017–2021Patents assigned to HOFFMANN LA ROCHE (8)· patent assignee history
2018–2021Based in South Plainfield, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PTC THERAPEUTICS INC | 20 | 2012–2021 |
| HOFFMANN LA ROCHE | 8 | 2017–2021 |
| WELCH ELLEN | 4 | 2012–2015 |
| NARYSHKIN NIKOLAI Aself | 3 | 2015 |
| PAUSHKIN SERGEY V | 3 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| East Brunswick, New Jersey, US | 18 | 2012–2020 |
| South Plainfield, New Jersey, US | 2 | 2018–2021 |